Pot Matters: The Shocking Truth About Edible Cannabis Candy

By
Jon Gettman

One of the new scare campaigns used by opponents of marijuana’s legalization is focused on edible cannabis products in general and edible cannabis candy in particular.

While there are some legitimate concerns about edible cannabis products—over dosages and product labeling—these are easily addressed by regulations such as those adopted in Colorado.

However, legalization opponents are quite concerned over edible cannabis candies, and they want to convince the public these are designed to entice children.  For example, in an article about the now-notorious “Kevin” ad, Boston Magazine reports this claim by Nick Bayer, campaign manager for Safe and Healthy Massachusetts: “Passing Question 4 means we will see the advertising and sale of highly potent marijuana candies, an increase in drugged driving on our roads, and marijuana shops popping up in our neighborhoods.”

But the shocking truth about “highly potent marijuana candies” is that these types of products are conventional products in most pharmacies, but they contain other pharmacological products rather than cannabis.

Step back from the campaign rhetoric and return to some of the early arguments about medical cannabis. Opponents argued that medicinal drugs are not smoked. In other words, there has been long-argued concerns that there are problems for some patients which make smoking cannabis unadvisable. The concern here is over the delivery method for getting cannabinoid drugs into the body. Oral ingestion, by way of edible products, is an alternative delivery method for cannabinoid drugs that is better suited for the needs of many patients.

Adjusting the delivery method for therapeutic drugs is a common practice in the pharmaceutical industry. The use of alternative medicine forms is a widespread and respected practice. Many pharmacies advertise this service to their potential customers.

The Professional Compounding Centers of America (PCCA) describes many of the common alternatives offered by the modern pharmacy. Available dosage forms include capsule, oral liquids, troches or lollipops, topical preparations, suppositories, eye and ear drops and nasal sprays, and sterile injections. Also, the use of custom flavoring is popular, particularly in oral liquids and lollipops, which are enhanced with sweeteners and pleasant-tasting flavors.

So, really, the cannabis candy issue is nothing new.

It’s just one more item in our complex world that requires appropriate precautions by responsible adults. There are a lot of things adults need to keep away from children, especially when it comes to drugs and common household products (like detergent packets and cleaning chemicals). Does the public get hysterical about glasses of scotch being left over night on living room tables where children could pick them up and drink them in the morning? Is it a public policy emergency that pharmacies prepare morphine lollipops for patients in chronic pain?

Edible cannabis candy is an innovative product designed to meet consumer needs, particular the needs of medical cannabis patients. The product has costs and benefits, with costs here referring specifically to the need for safety-oriented precautions. The products need to be adequately labeled, with information about dosage and a warning to keep the product away from the reach of children. Consumers need to be educated about the proper use of these products and about appropriate safeguards.

These are regulatory and public education issues—not obstacles in the way of legalization.

Previously in Pot Matters: The Most Dangerous Question for MMJ After the Election 

Read all of Jon Gettman’s columns right here.

Jon Gettman

Jon Gettman is the Cannabis Policy Director for High Times. Jon has a Ph.D. in public policy, teaching undergraduate criminal justice and graduate level management courses. A long-time contributor to High Times, his research and analytical work has been used by NORML, Marijuana Policy Project, American’s for Safe Access, the Drug Policy Foundation, the American Civil Liberties Union and other organizations. Jon’s research contributions to the topic of marijuana law reform have included findings on the economic value of domestic marijuana cultivation, attempts to have marijuana rescheduled under federal law and racial disparities in marijuana possession arrest rates. Serving as NORML’s National Director in the late 1980s, he was instrumental in creating NORML’s activist program.

By
Jon Gettman

Recent Posts

Ohio GOP Lawmakers Debate Adult-Use MJ Priorities, Eye June for Regulation Approval

Ohio's recreational market remains in limbo, for now.

1 hour ago

Study: Psilocybin Enhances Meditation

For those seeking enlightenment through meditation, psilocybin might do the trick.

1 hour ago

Cannabis Community, Investors React to DEA Decision To Reschedule

Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many…

1 hour ago

Georgia Governor Signs Bill Establishing Licensing Requirements To Grow Hemp

The governor of Georgia signed a series of bills aimed at bolstering the state’s agriculture…

1 hour ago

Taylor Swift Puts Narcotics Into All of Her Songs on ‘The Tortured Poets Department’

On her latest album, the megastar is more open about substance abuse than ever before.

1 hour ago

New Mexico Governor Calls Homeland Security Secretary’s Response to Pot Seizures ‘Inappropriate’

Governor Michelle Lujan Grisham was “offended” by Homeland Security Secretary Alejandro Mayorkas’ response to her…

1 day ago